Amarin sues U.S. FDA on free speech grounds over off-label speech
May 07, 2015 at 16:59 PM EDT
May 7 (Reuters) - Amarin Corp Plc filed suit against the U.S. Food and Drug Administration on Thursday for restricting its right to promote its fish oil drug Vascepa for an unapproved, or off-label, use.
